Novartis announces the company’s fourth quarter and 2020 full year financial results.

Jan 26, 2021

Media Releases

Download the media release
English (PDF 0.6 MB )  |  Deutsch (PDF 0.2 MB)  |  Français (PDF 0.3 MB)

Condensed financial report (PDF 0.8 MB)


Video - Financial Results 2020


Webcasts and presentations

Press conference

Watch the virtual press conference

Download the press conference presentation (PDF 1.4 MB)

Investors

Watch the investor webcast

Download the podcast (MP3 45 MB)

Download the investor presentation (PDF 6.0 MB)

Access our interactive slide deck (PDF 12 MB)


Annual Reporting 2020

Annual Report 2020

Novartis Annual Report 2020

This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices.

View the Novartis Annual Report 2020 (SIX filing) (PDF 4.0 MB)

Annual Review 2020

Novartis Annual Review 2020

The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2020.

English (PDF 7.0 MB) | Deutsch (PDF 7.0 MB)

The digital and interactive version of the Annual Review is available here.

Novartis in Society ESG report 2020

Novartis in Society ESG Report 2020

The Novartis in Society ESG Report details progress on environmental, social and governance topics and demonstrates the company’s commitment in global health and corporate responsibility.

Download the report (PDF 6.0 MB)

The digital and interactive version of the Novartis in Society ESG Report is available here


Financial Results on Social Media 


Novartis Pipeline

For a detailed review of selected projects in confirmatory development, download the complete Novartis Pipeline (PDF 0.1 MB), as of December 31, 2020.

Explore the Novartis Pipeline


Executive Committee of Novartis (ECN) Biographies

ECN Biographies


The information in the presentation on this page was factually accurate on the date of publication. This presentation remains on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.